Bird & Bird advised Fonds Patient Autonome and Uniqa Ventures on their €4 million financing round of Fizimed

International law firm Bird & Bird advised Fonds Patient Autonome, managed by Bpifrance, and Uniqa Ventures on their participation in the €4 million financing round of Fizimed, a femtech dedicated to women's health.

The Fonds Patient Autonome and Uniqa Ventures led the financing round, in which UI Investissement also participated.

The Bird & Bird team advising Fonds Patient Autonome and Uniqa Ventures comprised of partner Carole Bodin and associate Pascaline Sagot, who advised on the corporate aspects, with partner Alexandre Vuchot and associate Caroline Arrighi-Savoie advising on the regulatory aspects.

The company was advised by Charles Russell Speechlys. The team comprised of partner Renaud Ferry and Counsel Orlando Vignoli Neto.

News & Deals

More News & Deals
Deal Bird & Bird advises ECBF on Series A financing round in Vegdog

Sep 16 2025

Read More
Deal Bird & Bird advises the University of Hong Kong on the acquisition of a building in Barcelona for its first educational project in Europe

Sep 16 2025

Read More
News Bird & Bird appoints Chris Case as partner in Australia

Sep 16 2025

Read More
Deal Bird & Bird advises Kingyue International and Evolve Capital on Mandatory Unconditional Cash Offer for Samko Timber

Sep 15 2025

Read More
News Bird & Bird appoints energy expert Jenny Murray as new partner

Sep 15 2025

Read More
News Bird & Bird strengthens disputes capability in Life Sciences with French partner appointment

Sep 15 2025

Read More